HPi2 monoclonal antibody supernatant from hybridoma HIC1-2B4 (endocrine cell marker)

Case ID:
1038B
Web Published:
9/16/2020
Description:

Technology Overview

The monoclonal antibody HPi2 is derived from the hybridoma HIC1-2B4.  HPi2 selectively reacts with a cell surface module on human pancreatic endocrine cells. This antibody reacts with multiple endocrine cell types.
 
Antibody: HPi2 Supernatant
Hybridoma cell line: HIC1-2B4
Isotype: Mouse IgG1
Species reactivity: Human
Applications: Immunohistochemistry (acetone fixation recommended), Flow cytometry
Availability:  1mL supernatant aliquot.
 
 
 
Patent Information:
For Information, Contact:
Cadence True
Technology Collaboration Manager
Oregon Health & Science University
trueca@ohsu.edu
Inventors:
Philip Streeter
Markus Grompe
Craig Dorrell
Stephanie Abraham
Kelsea Shoop
Keywords:
Biological Materials
Biological Materials - Antibodies
Research Tools
Research Tools - Reagents
© 2024. All Rights Reserved. Powered by Inteum